Home Healthcare IT Pemetrexed Market Size, Share, Company Insights, Trends, Analysis, Forecast 2031

Pemetrexed Market Size, Share & Trends Analysis Report By Application (Malignant Pleural Mesothelioma, Non-Squamous NSCLC), By End-User (Hospitals, Oncology Centers, Online Pharmacies, Offline Pharmacies) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2023-2031

Report Code: SRHI208DR
Last Updated : Mar 21, 2024
Author : Straits Research
Starting From
USD 2300
Buy Now

Table Of Content

  1. Executive Summary

    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends

    1. Global Pemetrexed Market Introduction
    2. By Application
      1. Introduction
        1. Application By Value
      2. Malignant Pleural Mesothelioma
        1. By Value
      3. Non-Squamous NSCLC
        1. By Value
    3. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals
        1. By Value
      3. Oncology Centers
        1. By Value
      4. Online Pharmacies
        1. By Value
      5. Offline Pharmacies
        1. By Value
    1. Introduction
    2. By Application
      1. Introduction
        1. Application By Value
      2. Malignant Pleural Mesothelioma
        1. By Value
      3. Non-Squamous NSCLC
        1. By Value
    3. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals
        1. By Value
      3. Oncology Centers
        1. By Value
      4. Online Pharmacies
        1. By Value
      5. Offline Pharmacies
        1. By Value
    4. U.S.
      1. By Application
        1. Introduction
          1. Application By Value
        2. Malignant Pleural Mesothelioma
          1. By Value
        3. Non-Squamous NSCLC
          1. By Value
      2. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals
          1. By Value
        3. Oncology Centers
          1. By Value
        4. Online Pharmacies
          1. By Value
        5. Offline Pharmacies
          1. By Value
    5. Canada
    1. Introduction
    2. By Application
      1. Introduction
        1. Application By Value
      2. Malignant Pleural Mesothelioma
        1. By Value
      3. Non-Squamous NSCLC
        1. By Value
    3. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals
        1. By Value
      3. Oncology Centers
        1. By Value
      4. Online Pharmacies
        1. By Value
      5. Offline Pharmacies
        1. By Value
    4. U.K.
      1. By Application
        1. Introduction
          1. Application By Value
        2. Malignant Pleural Mesothelioma
          1. By Value
        3. Non-Squamous NSCLC
          1. By Value
      2. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals
          1. By Value
        3. Oncology Centers
          1. By Value
        4. Online Pharmacies
          1. By Value
        5. Offline Pharmacies
          1. By Value
    5. Germany
    6. France
    7. Spain
    8. Italy
    9. Russia
    10. Nordic
    11. Benelux
    12. Rest of Europe
    1. Introduction
    2. By Application
      1. Introduction
        1. Application By Value
      2. Malignant Pleural Mesothelioma
        1. By Value
      3. Non-Squamous NSCLC
        1. By Value
    3. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals
        1. By Value
      3. Oncology Centers
        1. By Value
      4. Online Pharmacies
        1. By Value
      5. Offline Pharmacies
        1. By Value
    4. China
      1. By Application
        1. Introduction
          1. Application By Value
        2. Malignant Pleural Mesothelioma
          1. By Value
        3. Non-Squamous NSCLC
          1. By Value
      2. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals
          1. By Value
        3. Oncology Centers
          1. By Value
        4. Online Pharmacies
          1. By Value
        5. Offline Pharmacies
          1. By Value
    5. Korea
    6. Japan
    7. India
    8. Australia
    9. Taiwan
    10. South East Asia
    11. Rest of Asia-Pacific
    1. Introduction
    2. By Application
      1. Introduction
        1. Application By Value
      2. Malignant Pleural Mesothelioma
        1. By Value
      3. Non-Squamous NSCLC
        1. By Value
    3. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals
        1. By Value
      3. Oncology Centers
        1. By Value
      4. Online Pharmacies
        1. By Value
      5. Offline Pharmacies
        1. By Value
    4. UAE
      1. By Application
        1. Introduction
          1. Application By Value
        2. Malignant Pleural Mesothelioma
          1. By Value
        3. Non-Squamous NSCLC
          1. By Value
      2. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals
          1. By Value
        3. Oncology Centers
          1. By Value
        4. Online Pharmacies
          1. By Value
        5. Offline Pharmacies
          1. By Value
    5. Turkey
    6. Saudi Arabia
    7. South Africa
    8. Egypt
    9. Nigeria
    10. Rest of MEA
    1. Introduction
    2. By Application
      1. Introduction
        1. Application By Value
      2. Malignant Pleural Mesothelioma
        1. By Value
      3. Non-Squamous NSCLC
        1. By Value
    3. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals
        1. By Value
      3. Oncology Centers
        1. By Value
      4. Online Pharmacies
        1. By Value
      5. Offline Pharmacies
        1. By Value
    4. Brazil
      1. By Application
        1. Introduction
          1. Application By Value
        2. Malignant Pleural Mesothelioma
          1. By Value
        3. Non-Squamous NSCLC
          1. By Value
      2. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals
          1. By Value
        3. Oncology Centers
          1. By Value
        4. Online Pharmacies
          1. By Value
        5. Offline Pharmacies
          1. By Value
    5. Mexico
    6. Argentina
    7. Chile
    8. Colombia
    9. Rest of LATAM
    1. Pemetrexed Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Eli Lilly and Company
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Stada Arzneimittel AG
    3. Eagle Pharmaceuticals, Inc
    4. Fresenius Kabi USA
    5. Teva Pharmaceuticals USA Inc
    6. Biocon
    7. Pfizer Inc.
    8. Apotex Inc
    9. Dr. Reddys Laboratories Ltd
    10. Cadila Pharmaceuticals.
    11. Accord Healthcare
    12. Accure Labs Pvt. Ltd
    13. Shanghai Henlius Biotech, Inc.
    14. Janssen Global Services LLC
    15. Checkpoint Therapeutics, Inc.
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
The global bispecific antibodies market size was valued at USD 8.2 billion in 2023 and is projected to reach a value of USD 224.6 billion by 2032, registering a CAGR of 44.4% during the forecast period (2024-2032). The rise in cancer incidence is a c
Buy Now
Global Report
The global X-Ray Inspection System Market size was valued at USD 734.5 Million in 2022 and is projected to reach USD 1231.3 Million by 2031, registering a CAGR of 6.6% during the forecast period (2023-2031). The rising awareness of the bene
Buy Now
Global Report
Inflight Catering Market Size and Trends The global inflight catering market size was valued at USD 13.62 billion in 2023. It is projected to reach from USD 15.16 billion in 2024 to USD 35.75 billion by 2032, growing at a CAGR of 11.32% during the f
Buy Now
Global Report
Bladder Scanners Market Size The global bladder scanners market size was valued at USD 149.28 million in 2024 and is projected to grow from USD 162.36 million in 2025 to reach USD 270.46 million by 2033, exhibiting a CA
Buy Now
Global Report
Hair Removal Wax Market Size The global hair removal wax market size was valued at USD 14426.26 million in 2024 and is projected to reach from USD 15133.14 million in 2025 to USD 22188.76 million by 2033, growing at a CAGR of 4.9% during t
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report


We are featured on :